Retention of African American women in cancer genetics research

American Journal of Medical Genetics, Part A

Volumn 146, Issue 2, 2008, Pages 166-173

  Halbert, Chanita Hughes ^a,d   Love, Deja ^b   Mayes, Tynisha ^c,d   Collier, Aliya ^d   Weathers, Benita ^d   Kessler, Lisa ^d   Stopfer, Jill ^a   Bowen, Deborah ^e   Domchek, Susan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LINCOLN UNIVERSITY   (United States)

^c Aquaculture Research and Education Laboratory   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

African American; Cancer genetics; Research; Retention

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BRCA2 ONCOGENE; BREAST CANCER; CANCER GENETICS; CANCER RESEARCH; CANCER RISK; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

AFRICAN AMERICANS; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; OVARIAN NEOPLASMS; RETENTION (PSYCHOLOGY); RISK FACTORS;

EID: 37849043106     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32067     Document Type: Article

References (30)

1. American Cancer Society. 2006. Cancer facts and figures. Atlanta, GA: American Cancer Society.
2. Ariail K, Watts CC, Bowen DJ. 2006. Retention in a breast cancer risk information trial: Motivations of a population-based sample of women. Health Educ Behav 33:591-603.
3. Baty BJ, Kinney AY, Ellis SM. 2003. Developing culturally sensitive cancer genetics communication aids for African Americans. Am J Med Genet Part A 118A:146-155.
4. Baty BJ, Dudley WN, Musters A, Kinney AY. 2006. Uncertainty in BRCA1 cancer susceptibility testing. Am J Med Genet Part C Semin Med Genet 142C:241-250.
5. Charles S, Kessler L, Stopfer JE, Domchek S, Halbert CH. 2006. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns 63:196-204.
6. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL. 1997. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415.
7. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. 2003. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21:593-601.
8. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC. 2002. Clinical characteristics of individuals with germline mutations in BRCA1 and BRC A2: Analysis of 10,000 individuals. J Clin Oncol 20:1480-1490.
9. Green MJ, Peterson SK, Baker MW, Harper GR, Friedman LC, Rubinstein WS, Mauger DT. 2004. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: A randomized controlled trial. JAMA 292:442-452.
10. Halbert CH, Lynch H, Lynch J, Main D, Kucharski S, Rustgi AK, Lerman C. 2004a. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 164:1881-1887.
11. Halbert CH, Schwartz MD, Wenzel L, Narod S, Peshkin BN, Cella D, Lerman C. 2004b. Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med 27:373-392.
12. Halbert C, Kessler L, Collier A, Paul Wileyto E, Brewster K, Weathers B. 2005a. Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer. Clin Genet 68:222-227.
13. Halbert CH, Brewster K, Collier A, Smith C, Kessler L, Weathers B, Stopfer JE, Domchek S, Wileyto EP. 2005b. Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol 23:7967-7973.
14. Halbert CH, Kessler L, Stopfer JE, Domchek S, Wileyto EP. 2006. Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med 8:576-582.
15. Hughes C, Lerman C, Lustbader E. 1996. Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 40:25-35.
16. Hughes C, Fasaye GA, LaSalle VH, Finch C. 2003. Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 51:107-114.
17. Hughes C, Peterson SK, Ramirez A, Gallion KJ, McDonald PG, Skinner CS, Bowen D. 2004. Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 13:1146-1155.
18. Johnson RE, Williams RD, Nagy MC, Fouad MN. 2003. Retention of under-served women in clinical trials: A focus group study. Ethn Dis 13:268-278.
19. Kinney AY, Bloor LE, Mandal D, Simonsen SE, Baty BJ, Holubkov R, Seggar K, Neuhausen S, Smith K. 2005. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation. Cancer 104:2508-2516.
20. Kinney AY, Simonsen SE, Baty BJ, Mandal D, Neuhausen SL, Seggar K, Holubkov R, Smith K. 2006. Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred. Am J Med Genet Part A 140A:813-826.
21. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H. 1996. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 275:1885-1892.
22. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, Eads N, Hadley D, Lynch J. 1999. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 8:361-367.
23. Moorman PG, Skinner CS, Evans JP, Newman B, Sorenson JR, Calingaert B, Susswein L, Crankshaw TS, Hoyo C, Schildkraut JM. 2004. Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev 13:1349-1354.
24. Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI. 2005. Genetic testing in an ethnically diverse cohort of high-risk women: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925-1933.
25. Parmigiani G, Berry D, Aguilar O. 1998. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BR CA2. Am J Hum Genet 62:145-158.
26. Satia JA, Galanko JA, Rimer BK. 2005. Methods and strategies to recruit African Americans into cancer prevention surveillance studies. Cancer Epidemiol Biomarkers Prev 14:718-721.
27. Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C. 2002. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 20:514-520.
28. Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, Lawrence W, Main D, Finch C, Magnant C, Pennanen M, Tsangaris T, Willey S, Isaacs C. 2004. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 22:1823-1829.
29. Schwartz MD, Tercyak KP, Peshkin BN, Valdimarsdottir H. 2005. Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility? Nat Clin Pract Oncol 2:24-25.
30. Shavers VL, Lynch CF, Burmeister LF. 2001. Factors that influence African-Americans' willingness to participate in medical research studies. Cancer 91:233-236.